| |
| |
|
| Insider
Information: |
Patel Sanj K |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
63,012 |
|
|
Indirect Shares
|
109,795 |
|
|
| Direct
Value |
$1,214,241 |
|
|
|
Indirect Value
|
$2,115,750 |
|
|
| Total
Shares |
172,807 |
|
|
| Total
Value |
$3,329,991 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
63,012 |
2024-04-08 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2022-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,555 |
23,202 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-09 |
4 |
OE |
$1.59 |
$32,438 |
D/D |
20,401 |
20,401 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-09 |
4 |
AS |
$23.04 |
$470,039 |
D/D |
(20,401) |
0 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-08 |
4 |
AS |
$49.49 |
$1,073,686 |
D/D |
(21,695) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-08 |
4 |
OE |
$0.95 |
$20,610 |
D/D |
21,695 |
22,726 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-04 |
4 |
AS |
$50.12 |
$1,102,315 |
D/D |
(21,931) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-04 |
4 |
OE |
$0.95 |
$20,834 |
D/D |
21,931 |
22,962 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-04 |
4 |
OE |
$0.95 |
$21,850 |
D/D |
23,000 |
24,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-04 |
4 |
AS |
$49.34 |
$1,134,850 |
D/D |
(23,000) |
1,031 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-09 |
4 |
AS |
$23.08 |
$543,973 |
I/I |
(23,569) |
84,473 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-02-20 |
4 |
OE |
$0.95 |
$23,378 |
D/D |
24,608 |
25,639 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-02-20 |
4 |
AS |
$49.49 |
$1,218,505 |
D/D |
(24,608) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-06-11 |
4 |
OE |
$0.95 |
$28,166 |
D/D |
29,648 |
30,679 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-06-11 |
4 |
AS |
$40.89 |
$1,212,307 |
D/D |
(29,648) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-03 |
4 |
AS |
$49.42 |
$1,482,492 |
D/D |
(30,000) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-03 |
4 |
OE |
$0.95 |
$28,500 |
D/D |
30,000 |
31,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-07-25 |
4 |
OE |
$0.95 |
$45,319 |
D/D |
31,915 |
32,946 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-17 |
4 |
AS |
$45.97 |
$1,513,338 |
D/D |
(32,319) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-17 |
4 |
OE |
$0.95 |
$30,703 |
D/D |
32,319 |
33,350 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-03-06 |
4 |
AS |
$20.00 |
$662,300 |
I/I |
(33,115) |
212,570 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-06-12 |
4 |
OE |
$0.95 |
$49,383 |
D/D |
40,352 |
41,383 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-06-12 |
4 |
AS |
$40.48 |
$1,633,449 |
D/D |
(40,352) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-02-21 |
4 |
AS |
$49.02 |
$2,225,116 |
D/D |
(45,392) |
1,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-02-21 |
4 |
OE |
$0.95 |
$43,122 |
D/D |
45,392 |
46,423 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-03-23 |
4 |
AS |
$33.53 |
$1,676,410 |
D/D |
(50,000) |
1,031 |
0 |
- |
|
93 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
